BioPharm International
CONTINUE TO SITE >

OR WAIT 15 SECS

Ravindra Khare

Ravindra Khare is CSO of SymphonyTech Biologics

Articles

A Systematic Evaluation of Risks and Mitigation Strategies for Convalescent Plasma Therapy for COVID-19

A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis